Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile pompe disease: a step towards improving the efficacy of ERT.
Although enzyme replacement therapy (ERT) is a highly effective therapy, CRIM-negative (CN) infantile Pompe disease (IPD) patients typically mount a strong immune response which abrogates the efficacy of ERT, resulting in clinical decline and death. This study was designed to demonstrate that immune...
Main Authors: | Suhrad G Banugaria, Sean N Prater, Trusha T Patel, Stephanie M Dearmey, Christie Milleson, Kathryn B Sheets, Deeksha S Bali, Catherine W Rehder, Julian A J Raiman, Raymond A Wang, Francois Labarthe, Joel Charrow, Paul Harmatz, Pranesh Chakraborty, Amy S Rosenberg, Priya S Kishnani |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3692419?pdf=render |
Similar Items
-
Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease
by: Baodong Sun, et al.
Published: (2014-01-01) -
Characterization of immune response in Cross-Reactive Immunological Material (CRIM)-positive infantile Pompe disease patients treated with enzyme replacement therapy
by: Ankit K. Desai, et al.
Published: (2019-09-01) -
Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
by: Deeksha S. Bali, et al.
Published: (2015-12-01) -
Immune responses and hypercoagulation in ERT for Pompe disease are mutation and rhGAA dose dependent.
by: Sushrusha Nayak, et al.
Published: (2014-01-01) -
MRI assessment of left ventricular structure and function in children with infantile Pompe disease
by: Kishnani Priya, et al.
Published: (2010-01-01)